Skip to main content
Caplight Logo









Abtrace

Abtrace

Private
LondonHealthcare & Life Scienceshttps://www.abtrace.com/

Last Round

Seed

Aug 26, 2021

Total Funding Raised

$5.16M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Abtrace is a healthtech company that provides an AI-driven software platform for proactive monitoring and intelligent recall in primary care settings.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Medical AI, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinical decision supportCDSSelectronic health recordEHRprimary care softwarehealth techpatient safety softwareclinical monitoringautomated recallmedical AIhealthcare analyticsvertical SaaSNHS softwareAI scribedigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abtrace Comparables

Compare Abtrace with similar companies based on industry and business-model similarity.

Abtrace comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medlink Solutions Ltd
87%
Ardens Health Informatics
86%
C the Signs
85%

Abtrace Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 26, 2021
AcceleratorNov 23, 2018

Key People

Founding team and executive leadership

Cristina Correia

Co-Founder Chief Compliance Officer

Founding Team

Umar Naeem Ahmad

Chief Executive Officer

Executive Team

Kerim Suruliz

Chief Technology Officer

Executive Team

Helder Soares

Chief Operating Officer

Executive Team

Abtrace Investors

Notable investors and investment history

Abtrace investors
InvestorRounds
Innovate UKSeed
UKRI Innovate UKAccelerator
EIT HealthAccelerator
Faber VenturesSeed
Ganexa CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 40% MoM, reaching 8.5K.

  • Aug 21, 2026

    Grew 16% QoQ, from 51 to 59 employees.

Abtrace Filings

Explore SEC and related filing metadata, where available.

Abtrace filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Abtrace's valuation, stock price, and market status.

Is Abtrace a public or private company?

Abtrace is a private company.

What is the current stock price of Abtrace?

Abtrace is a private company with no public stock price. No recent secondary market data is available.

How much is Abtrace worth (valuation)?

Valuation information for Abtrace is not publicly available.

Can I buy Abtrace stock?

Abtrace shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Abtrace's last funding round?

Abtrace's most recent funding round was Seed on August 26, 2021.

Who are the main investors in Abtrace?

Key investors in Abtrace include Innovate UK, UKRI Innovate UK, EIT Health.

Will Abtrace IPO soon?

No public IPO plans have been announced for Abtrace.

How can I track Abtrace secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abtrace's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range55
Year Founded2018
Last FundingAug 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?